Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic differences between beta blockers.

A J Wood

    American Heart Journal
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Beta blockers antagonize adrenergic agonists at beta-adrenergic receptors, with significant pharmacologic differences among agents. Selective beta blockers are preferred for asthma patients, but nonselective agents may counter metabolic effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Life on the dry side: a roadmap to understanding desiccation tolerance and accelerating translational applications.

    Nature communications·2025
    Same author

    The utility of whole-genome sequencing to identify likely transmission pairs for pathogens with slow and variable evolution.

    Epidemics·2024
    Same author

    The readability and reliability of online information about adenoidectomy.

    The Journal of laryngology and otology·2021
    Same author

    FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.

    Nature communications·2021
    Same author

    A policy of day-case sinonasal surgery is safe, well tolerated and cost-effective.

    The Journal of laryngology and otology·2021
    Same author

    Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A.

    NPJ Regenerative medicine·2019
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    Same journal

    Considerations for Using Atrial Fibrillation Burden as a Surrogate Endpoint A Report from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    Prognostic Impact of Combined Inflammatory Markers in Patients Undergoing Percutaneous Coronary Intervention.

    American heart journal·2026
    Same journal

    The Association of Single Ventricle Morphology with Long Term Quality of Life Among Survivors: A Report from CHD PULSE (Congenital Heart Disease Project to Understand Lifelong Survivor Experience).

    American heart journal·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Beta blockers function by antagonizing epinephrine and norepinephrine at beta-adrenergic receptors.
    • Significant pharmacologic variations exist among different beta-blocking agents.

    Purpose of the Study:

    • To elucidate the pharmacologic differences between various beta-blocking agents.
    • To discuss the implications of these differences in clinical practice, particularly for patients with asthma.

    Main Methods:

    • Review of existing literature on beta-blocker pharmacology.
    • Comparison of selective and nonselective beta-blockers.
    • Discussion of intrinsic sympathomimetic and membrane-stabilizing activities.

    Main Results:

    • Selective beta blockers (e.g., atenolol, metoprolol) target beta-1 receptors, but can affect beta-2 at higher doses.

    Related Experiment Videos

  • Nonselective beta blockers may be beneficial for counteracting epinephrine-induced metabolic effects like hypokalemia.
  • Pindolol exhibits intrinsic sympathomimetic activity, while propranolol has membrane-stabilizing effects.

    • Conclusions:

    • Clinical use of beta blockers requires consideration of their selectivity, intrinsic activities, and pharmacokinetic profiles.
    • Low doses of selective beta blockers are recommended for asthma patients.
    • Further research may clarify the non-beta blockade mechanisms of certain beta blockers.